Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.81 USD | +1.61% | +4.63% | +35.54% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.54% | 56Cr | |
-2.47% | 8.94TCr | |
+2.76% | 4.07TCr | |
-12.92% | 3.28TCr | |
+54.69% | 2.5TCr | |
-16.51% | 1.53TCr | |
-8.27% | 1.29TCr | |
-42.60% | 1.16TCr | |
-12.82% | 1.15TCr | |
+7.34% | 898.19Cr |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices : KeyBanc Adjusts Avid Bioservices' Price Target to $28 From $22, Reiterates Overweight Rating